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Abstract
Background: Stigma is associated with health conditions that drive disease burden in low- and middle-income
countries (LMICs), including HIV, tuberculosis, mental health problems, epilepsy, and substance use disorders. However,
the literature discussing the relationship between stigma and health outcomes is largely fragmented within disease-
specific siloes, thus limiting the identification of common moderators or mechanisms through which stigma
potentiates adverse health outcomes as well as the development of broadly relevant stigma mitigation interventions.
Methods: We conducted a scoping review to provide a critical overview of the breadth of research on stigma for each
of the five aforementioned conditions in LMICs, including their methodological strengths and limitations.
Results: Across the range of diseases and disorders studied, stigma is associated with poor health outcomes, including
help- and treatment-seeking behaviors. Common methodological limitations include a lack of prospective studies, non-
representative samples resulting in limited generalizability, and a dearth of data on mediators and moderators of the
relationship between stigma and health outcomes.
Conclusions: Implementing effective stigma mitigation interventions at scale necessitates transdisciplinary longitudinal
studies that examine how stigma potentiates the risk for adverse outcomes for high-burden health conditions in
community-based samples in LMICs.
Keywords: Stigma, Low- and middle-income countries, HIV, Tuberculosis, Epilepsy, Depression, Substance use,
Scoping review
Background
Stigma is a major social determinant of health that
drives morbidity, mortality, and health disparities [1],
and has been described by the World Health
Organization as a ‘hidden’ burden of disease [2]. Stigma
is characterized by cognitive, emotional, and behavioral
components and can be reflected both in the attitudes,
often conceptualized as perceived, anticipated, or inter-
nalized stigmas, and experiences, including enacted or
experienced stigmas affecting a particular trait, among
individuals [3–5]. Perceived stigma refers to a person’s
understanding of how others may act towards, and think
or feel about, an individual with a certain trait or iden-
tity [6]. Anticipated stigma refers to expectations of
stigma experiences happening in the future [7]. Internal-
ized stigma refers to the individual level process of
awareness, acceptance, and application of stigma (to
oneself ) [8–10]. Finally, experienced or enacted stigma
refers to discriminatory acts or behaviors [11].
Stigma adversely impacts individual health outcomes as
well as related ‘life chances’, including educational oppor-
tunities, employment, housing, and social relationships
[1]. It has also been shown to negatively affect help- and
treatment-seeking behaviors, hindering the ability of pub-
lic health agencies to treat and prevent stigmatized health
conditions [12]. HIV-related stigma, in particular, has been
cited as one of the most enduring barriers to ending the
HIV pandemic [13, 14]. Yet, while HIV-related stigma has
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received greater attention, tuberculosis (TB), mental,
neurological, and substance use disorders are also highly
stigmatized drivers of the global burden of disease, with
significant unmet treatment needs in low- and
middle-income countries (LMICs) [15–20].
Hatzenbuehler et al. [1] argued that research on stigma
and health outcomes is inappropriately siloed within
specific disease/disorder domains. Across health disci-
plines, this separation has limited the ability to under-
stand the overall impact of stigma on individual
wellbeing and on global disease burden [1]. Research si-
loes have also restricted our ability to develop interven-
tions addressing stigma, particularly in LMICs and
among at-risk populations (e.g., lesbian, gay, bisexual,
transgender, queer populations (LGBTQ); racial/ethnic
minorities; refugees) for whom effective interventions
are needed. Despite considerable progress in stigma re-
search over the past decade, a critical review of the lit-
erature on the consequences of stigma across health
conditions has not been undertaken.
This paper presents a scoping review of the literature
on the health consequences of stigma at both the indi-
vidual and healthcare system levels in LMICs. The re-
view focuses on the main drivers of disease burden in
LMICs, namely HIV, TB, mental health, epilepsy, and
substance use. The purpose is to summarize recent re-
search on the association between stigma and these con-
ditions, including the direct impact of stigma on affected
individuals and its indirect impact on health systems ac-
cording to help-seeking behavior or service utilization.
In so doing, this review highlights commonalities across
conditions as well as the key mediators and moderators
of the relationship between stigma and health, and iden-
tifies at-risk and vulnerable groups. Finally, the strengths
and limitations of the current state-of-the-science are
highlighted, and recommendations are made for future
studies measuring the health-related outcomes of stigma,
their pathways, and approaches for evidence-based inter-
ventions in LMICs.
Methods
Search strategy, data charting, and data summary
We conducted a scoping literature review [21] to
summarize current research on stigma and health in re-
lation to five high-burden conditions in LMICs,
highlighting the gaps and informing future directions
[22]. Five searches of peer-reviewed manuscripts pub-
lished between 2008 and 2017 were conducted between
November 2017 and February 2018 using the PubMed
(MEDLINE), PsychINFO, and EMBASE databases.
Searches included terms related to (1) ‘stigma’ or other
associated terms such as ‘discrimination’; (2) ‘LMICs’, in-
cluding all countries with this classification according to
the World Bank; and (3) specific diseases or disorders.
Epilepsy was selected to represent neurologic disorders
due to the lack of stigma data related to other neurologic
conditions. Additional file 1 includes the full list of
search terms for each database searched.
Each review and synthesis was conducted by a single
study author with condition-specific expertise. An initial
title and abstract review was performed, followed by
full-text review of any article included during the first
phase. For charting, data were extracted according to
study authors and year of publication, study design, sam-
ple size and sampling characteristics, type of stigma
measured (i.e., perceived, anticipated, internalized, expe-
rienced/enacted), strength and significance, if applicable,
of the stigma and health outcome association, and medi-
ators or moderators.
In reviewing stigma related to the five diseases/disor-
ders assessed, our team identified three populations
most adversely affected by stigma, namely LGBTQ indi-
viduals, racial and ethnic minorities, and refugees. Boxes
1, 2 and 3 present further details on the relationship be-
tween stigma and health for these populations, focusing
on commonalities across disorders.
Box 1. Population of concern: LGBTQ
A study done among transgender female sex workers in China
reveals limited access to services due to amplified stigma
because of their gender identity and their profession [230]. Thus,
many decide to engage in self-medication, especially for the
transitioning phase, including self-administering hormone use. A
case study exploring the economic costs of stigma in India
indicates different reasons; if discussing LGBTQ, it is the fear of
family deprecation, professional discrimination, and overall
societal rejection, yet healthcare providers confidentiality can
also lead to discrimination, ultimately leading to breach of human
rights [231]. All of them could potentially lead to adverse sexual
health outcomes, suicide, and depression. A study performed in
Vietnam [232], as a part of a case study series on researching
LGBTQ in Asia, found that due to the stigma around the
transgender society, transgender people end up doing their own
research on gender-confirmation surgery or self-inject cheap and
impure chemicals such as silicone and other petroleum products,
which in some cases lead to serious harm and even fatalities. The
same case study series, with findings from Nepal [233], reported
that LGBTQ encounter stigma on daily basis from an early age,
shaping how they perceive and interact with all aspects of society,
including healthcare. The vast number of institutions, including
those in Nepal, stigmatize gender and sexual minorities, with
important implications for the ability of healthcare providers and
institutions to address their health needs [233]..
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Results
Characteristics of included studies
The database search identified a total of 186 articles dis-
cussing one or more of the defined diseases and their rela-
tionship with stigma, including 59 articles on HIV (32%),
29 on TB (16%), 27 on mental health (14%), 25 on epilepsy
(13%), and 46 on substance use (25%) (Fig. 1). Across stud-
ies, 52 LMICs were represented, with 79 studies (43%) fo-
cusing on Asia, 70 (38%) on Africa, 21 (11%) on South and
Central America, 10 (5%) on Eastern Europe and Russia,
and 6 (3%) that included more than one region. The most
frequently included countries were China (n = 30),
India (n = 21), and South Africa (n = 19). Over half
of all included studies were published in 2015 or
later, with more publications in 2017 than in any
other year, suggesting that research attention to
stigma is growing (Fig. 2).
Internalized stigma was the most common stigma type
measured (44% of studies), whereas fewer studies
focused on experienced (enacted), anticipated, or
perceived stigma. Children and adolescents were under-
represented in the included studies, with less than 5% of
the included studies involving youth populations.
Cross-sectional (68%) and qualitative (15%) study de-
signs were most common, and only 9% of studies used
longitudinal data.
Herein, a summary of the reviews for each disease/
disorder is provided (Tables 1, 2, 3, 4 and 5), followed
by a discussion on the overlap and intersection of
these stigmas.
HIV
Among people with HIV, both internalized and experi-
enced stigma have been associated with increased preva-
lence of HIV-related symptoms and poorer self-reported
health [23–26] (Table 1). Internalized and experienced
HIV-related stigma have been associated with increased
prevalence of mental health disorders [27–29], particu-
larly depression [30–40] and anxiety [41, 42]. For ex-
ample, among Nigerians with HIV [43], stigma was
associated with a diagnosis of severe depression, al-
though it was not associated with mild or moderately se-
vere depression. Among Tanzanian youth [28] and
South African adults [28, 36], post-traumatic stress
Box 2. Population of concern: Racial and ethnic
minorities
Qualitative studies with refugee, asylum seeking, and immigrant
new mothers [234] with depressive symptoms seeking mental
health services, including a study with Korean American
immigrant women [235], showed a challenging path to recovery
due to social isolation and perceived stigma. A study that
explored depression and care among Asian Indians in the USA
collected data from interviews of 23 multidisciplinary mental
health professionals and retrospective review of 20 medical
records of patients [236]. Findings revealed that that social
stigma contributed to the prolonged denial of a condition,
difficulty in communicating the problem, and delayed
professional intervention in those suffering from depression.
People living with HIV are stigmatized and looked at negatively,
with the fear of discrimination preventing patients from
accessing care and the stigma remains a barrier to effectively
addressing the disease [237]. Immigrant HIV-positive Latina
women in the Midwest USA experienced feelings of stigma,
leading to depression, rejection, or suicidal attempts; few had
received any type of mental health care intervention [238]. Few
cases of self-imposed stigma or ‘self-stigma’ as a result of
minority status has led to reduced health-seeking behavior from
health professionals due to fear that disclosing the minority
status might be an obstacle from receiving care [239]. Similar
findings were presented as part of a qualitative study in mental
health among Asian communities in Australia and the unwillingness
to access help from healthcare services due to stigma and shame
[240]. Immigration and transmission of tuberculosis were reinforcing
each other’s stigma [241].
Box 3. Population of concern: Refugees
Tibetan refugees in Nepal faced different layers of barriers,
behavioral norms, and institutional structures that impair the
diffusion of relevant information, creating a challenge to
develop a comprehensive understanding of HIV/AIDS [242]. The
stigma in both host and their own societies was hindering the
individual’s willingness to discuss the issue with their peers and
with medical professionals [242]. A case study based on a
literature review and semi-structured interviews of urban refu-
gees in Egypt at high risk for HIV/AIDS [243] revealed that in-
tense stigma and discrimination, vulnerability, and social stability
resulted in a lack of adequate health resources and a chain of
causation that marginalized refugees in Egyptian society. These
social processes result in unequal access to health resources,
thereby increasing their potential exposure to HIV transmission.
The sexual violence being used as a weapon of war during
conflicts (conflict-related sexual violence) has caused significant
trauma in both women and men survivors. The experience of
refugees in Ethiopia shows that the stigma associated with
conflict-related sexual violence makes it challenging for the
survivors to mitigate the potential long-term physical, mental,
reproductive health, and social consequences [244].
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disorder was also more common among those with high
levels of internalized stigma. All forms of stigma have
been associated with decreased resilience and self-es-
teem among Chinese adults [32].
HIV-related stigma has been linked to poor health be-
haviors. Anticipated, experienced, and internalized
stigma have been repeatedly associated with decreased
voluntary HIV testing and disclosure of infection [24,
44–49]. For example, among Tanzanian adults obtaining
HIV services [50], internalized stigma has been linked to
increased denial of HIV infection. HIV-positive individ-
uals who report experienced (enacted) stigma are more
likely to delay initiation or continuation of HIV care [25,
51, 52]. Those who experience stigma in a healthcare
setting are also less likely to initiate antiretroviral ther-
apy [25]. Available cohort data suggests that perceived
stigma is associated with poor medication adherence ac-
cording to participant reports and chart reviews [53–55].
A longitudinal cohort study of adults living with HIV in
South Africa revealed that internalized stigma was asso-
ciated with a greater incidence of condomless sex with
both HIV-negative/unknown and HIV-positive partners
[5]. Finally, stigma has been associated with increases in
smoking, alcohol, and drug use [32], as well as with sui-
cidal ideation and attempted suicide [56, 57].
Significant mediators of the relationships between
HIV-related stigma and health outcomes included indi-
vidual resilience [23], depression, negative condom use
attitudes [5], and self-efficacy [58]. While most data
demonstrated an inverse relationship between quality of
life and HIV-related stigma [59–61], this relationship
may be mediated by depression [33, 38] and self-efficacy
[58]. The association between HIV stigma and depres-
sion has been shown to be moderated by individual
affect, social support, socioeconomic status, employment
status, rural versus urban residence, and disclosure
avoidance [32, 35, 62].
Tuberculosis
TB-related stigma negatively impacts health outcomes
by impeding healthcare seeking behavior, care delivery,
and recovery (Table 2). Qualitative and quantitative
studies have generally shown that stigma delays health-
care seeking, although a recent quantitative study did
not find a strong deterrent effect of TB-related stigma
when major drivers of healthcare seeking were included
in a model [63]. Additionally, TB-related stigma can
temporarily diminish social capital during treatment
[64], and damage to family reputation can impact
Fig. 2 Number of studies included by date of publication
Fig. 1 Characteristics of included studies
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Kane et al. BMC Medicine           (2019) 17:17 Page 30 of 40
employment, education, and the marriage prospects of
its members [65, 66].
Secondary stigma may manifest as a reluctance to ex-
pedite emergency care for acutely ill family members
due to fear of disease disclosure to the broader commu-
nity [66]. In communities where social capital functions
as the safety net, loss of social status can imperil family
survival [66, 67]. TB-related stigma was shown to dam-
age the support networks and quality of services given
to those who have a stigmatized condition [66]. Mis-
treatment of TB patients can contribute to mental health
sequelae, poor coping behaviors, and other comorbidities
[68, 69]. TB-related stigma may also erode patients’ re-
silience to disease and household-level wellbeing [70].
Finally, healthcare workers who perceive TB stigma defer
TB screening and prophylaxis [71].
Studies have suggested that the impact of stigma on
TB treatment adherence varies [72–74], with some sug-
gesting a decrease [75] and others an increase [76, 77] in
adherence. The predominance of cross-sectional data
limits the ability to tease apart this relationship. Much of
this variance can also likely be attributable to the diver-
sity across studies with regards to measurement metrics
and statistical power [78].
It is likely that drug-resistant TB (DRTB) has a differ-
ent impact on the association of TB-related stigma with
outcomes compared to drug-susceptible TB [79, 80].
DRTB disease may be more susceptible to blame, shame,
and self-stigma because healthcare workers often assume
it is caused by non-adherence. Further, DRTB treatment
side effects can expose DRTB patients to mental health,
disability, and poverty stigmas [81]. Stigma fed by per-
ceived dangerousness and isolation policies that erode
social capital and resilience may disproportionately affect
people with DRTB. DRTB-related stigma may also be
considered more of a barrier to adherence than HIV
stigma among co-morbid persons [79, 82].
TB-related stigma can be exacerbated or attenuated by
other forms of prejudice, including misogyny [83, 84].
Studies of TB-related stigma have also drawn attention to
the moderating role of gender. Two studies found women
were more adherent to TB treatment when they perceived
high levels of stigma, while men were less so, particularly
if they found TB treatment humiliating [65, 77]. There is
also evident variation in the health impacts of TB-related
stigma among sub-populations (e.g., people who inject
drugs, alcohol dependent, pastoralists) [85–87].
Mental health
Studies have indicated that mental health-related stigma
is negatively associated with quality of life, functioning,
and other positive health outcomes (Table 3). Quality of
life was associated with either internalized or perceived
stigma [89] and general functioning was inversely
associated with internalized and perceived stigma [88,
89]. Greater stigma was also associated with fatigue [90]
and poorer diabetes-related outcomes [91] among those
with depression, and with HIV-risk behaviors among
those with a severe mental illness [92].
Treatment outcomes were a major area of focus within
the mental health articles identified. For example, studies
on treatment adherence found internalized stigma to be
associated with poorer medication adherence both
among those with schizophrenia [93] and among those
with any diagnosis of a mental disorder [94]. Perceived
discrimination was also associated with higher odds of
discontinuing medication among individuals diagnosed
with schizophrenia [95]. Data on treatment-seeking be-
haviors for mental health problems were mixed. For ex-
ample, one study found that individuals identified as
having depression yet rejected treatment were more
likely to have higher internalized stigma relative to those
who accepted treatment [91]. In a community-based
study from Ukraine [96], only 8% of individuals who
were identified as having a mental health problem but
not having sought help from any medical source cited
stigma as a reason. However, nearly 75% of individuals
living with severe mental illness in India reported delay-
ing seeking care in part due to fear of stigma [97].
Symptom severity was the most common health-related
outcome tested for associations with stigma; however,
findings on the impacts of mental health-related stigma
on mental disorder symptom severity are mixed. For ex-
ample, two studies found that, among those diagnosed
with schizophrenia, those with higher levels of internalized
stigma had greater general psychiatric symptoms [88, 98].
In contrast, two studies found no relationship between
general symptoms of psychopathology and most forms of
internalized stigma assessed [89, 99], and one study found
fewer experiences of stigma among those with more se-
vere general psychiatric symptoms who were living with a
severe mental illness [92]. Findings related to symptoms
specific to schizophrenia were similarly mixed. Negative
schizophrenia symptoms were not significantly associated
with most forms of internalized stigma [35, 89, 99, 100].
Of three studies examining positive symptoms of schizo-
phrenia [99–101], two found significant associations with
stigma operating in opposite directions [99, 101]. For indi-
viduals with depression, greater symptom severity was as-
sociated with greater perceived stigma [90, 102–105],
though one study found less stigma among those with
higher levels of symptoms [99].
Moderators were assessed in only two studies on men-
tal health-related stigma and health outcomes and no
studies assessed mediators. In Jordan [106], depression
was a moderator of the relationship between stigma and
treatment seeking. Adolescents with mild depression
who reported high levels of stigma were more likely to
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seek care from a variety of sources (counselor, general
practitioner, religious leader, or family member) and ex-
press willingness to take medication or receive therapy
than adolescents with mild depression who reported low
levels of stigma. While moderate to severe depression
was associated with lower likelihood of seeking care
overall, there was no association between stigma and
care-seeking for adolescents with moderate to severe de-
pression. In Egypt [107], insight did not significantly
modify the relationship between stigma and suicide risk
among persons with schizophrenia.
Epilepsy
Epilepsy-related stigma has been repeatedly linked to
poor quality of life and associated with increased
epilepsy-related concerns [108, 109], poor self-esteem
[110], and increased self-reported burden of disease
[111], including increased psychiatric burden such as
that attributed to anxiety and depression [111–113]
(Table 4). Qualitative and quantitative data suggest that
epilepsy-related stigma leads to poor overall function,
particularly regarding social engagement and employ-
ment [111, 114, 115]. Further, increased stigma has been
associated with decreased disclosure and discussion
about epilepsy [116, 117]. For example, 34% of married
Pakistani women with epilepsy actively concealed their
epilepsy diagnosis during marriage negotiations in re-
sponse to misconceptions regarding their diagnosis,
pressure from family members, and to avoid rejection
and further stigmatization [118].
Epilepsy-associated stigma has also been shown to
affect family members of people with epilepsy. Among
mothers of children younger than 8 years with epilepsy,
stigma has been associated with increased maternal psy-
chopathology [119]. Mothers were also more likely to ac-
tively limit their child’s activities based on their own and
perceived interpretation of their child’s internalized
stigma [119].
Epilepsy-related stigma has been associated with social
withdrawal and adverse health behaviors such as poor
medication adherence [120]. This relationship may be
mediated by increased medication side-effects reported
among adults with epilepsy [121] as these side-effects
have previously been associated with increased stigma
[122, 123], though this relationship has yet to be for-
mally examined as none of the epilepsy studies included
in the review evaluated mediators or moderators.
Substance use
Stigma is often prevalent among persons who use alco-
hol or other substances in both the community and in
healthcare settings, with possible adverse consequences
(Table 5). Among persons using alcohol or other sub-
stances, substance-related stigma was identified as a
barrier to accessing drug treatment services [124, 125],
general healthcare services [124, 126], HIV testing [127,
128], reduced antiretroviral therapy or treatment adher-
ence [129–131], needle exchange programs [132], and to
recovery generally [133]. Stigma among persons who use
substances was also associated with less education and
not being employed full-time [134], as well as lower
quality of life across several domains, including the so-
cial, physical, psychological, and environmental domains
[135], higher risk of relapse [136], social isolation, anx-
iety, and depression [137]. Healthcare professionals and
trainees, including pharmacists and pharmacy students
[138], medical students and recent medical graduates
[139], and primary healthcare workers [140], expressed
stigmatizing beliefs and attitudes towards persons who
use drugs.
In addition to stigma occurring as a result of substance
use, stigma related to HIV and other health conditions
can also be associated with an increased risk for alcohol
and other substance misuse. HIV stigma was associated
with hazardous/harmful alcohol use among persons
co-infected with HIV and TB [141]. Further, among per-
sons with HIV and alcohol use, high levels of
HIV-related stigma were associated with increased odds
of experiencing physical and sexual violence [142].
Higher levels of HIV stigma were also associated with
other (non-alcohol) substance use [143]. Stigma not at-
tached to a health condition can also increase the risk of
alcohol and other substance use; indeed, recent discrim-
ination (e.g., based on race, age) was associated with in-
creased odds of both alcohol and drug use [144–146].
Two studies investigated moderators. Years of study at
university [145], income, and place of residence were
found to be significant moderators of stigma–substance
use relationships. One study investigated mediators and
found that, among men who have sex with men, alcohol
and substance use mediated the relationship between
stigma and risky sexual behaviors [147].
Intersectional stigmas
Stigmatized medical co-morbidities were common
across the five conditions. In many LMICs, the preva-
lence of HIV and TB can be high and the burden of
chronic non-infectious disorders like epilepsy, mental ill-
ness, and substance use is growing. HIV-related stigma
has been associated with harmful alcohol use among in-
dividuals with comorbid HIV and TB infection [87] as
well as increased (non-alcohol) substance use among in-
dividuals with HIV (alone) compared to those without
HIV [143]. Stigma due to other marginalized characteris-
tics (sex, race, gender, country of origin, etc.) also in-
creases the risk of substance use and physical and sexual
violence [142, 144–146]. This interaction has culminated
in a syndemic, with an increased burden of stigma [148].
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HIV-related stigma has been shown to attenuate the im-
pact of TB-related stigma in some settings [77, 149], while
potentiating it in others [150]. Comorbid stigmas do not
always result in worse health outcomes. For example,
while Zambian adults with HIV and epilepsy endorsed
greater stigma, this did not translate into an increased
prevalence of depression [151]. However, stigma due to
one medical condition, such as substance use, has also
been shown to hinder preventative care, including HIV
testing [127, 128] and, among individuals with comorbid
HIV infection, medication adherence [129–131].
Discussion
Across disease types included in this scoping review,
stigma was associated with poor individual health out-
comes and health utilization patterns. Stigmas related to
HIV, TB, epilepsy, and substance use were associated
with increased psychiatric morbidity, particularly depres-
sion and anxiety. Stigma has repeatedly been associated
with decreased quality of life and poorer functioning
across conditions. Highly stigmatized individuals are
more likely to conceal their condition and, as a result,
are less likely to seek care or more likely to delay care.
This is consistent with the literature from high-income
countries on stigma related to mental health conditions.
In a systematic review of 144 studies (the vast majority
of which were from high income countries) [152], the
median effect size of stigma on help-seeking for mental
health disorder was -0.27, though there was some evi-
dence that this relationship was stronger among ethnic
minority groups within these countries; qualitative stud-
ies suggested that this is both a direct relationship and
may be mediated through decreasing disclosure.
Among those obtaining treatment for all five condi-
tions examined in this review, stigma was associated
with decreased medication adherence and, among pa-
tients with substance use, relapse. In high-income coun-
tries, the relationships between treatment adherence and
stigma related to mental health problems is varied. Per-
ceived stigma has been found to predict poorer treat-
ment outcomes for individuals with depression [153,
154]; though this evidence is mixed, internalized stigma
has also been found to be related to poorer treatment
adherence for individuals living with multiple mental
health conditions [155]. Conversely, anticipated and ex-
perienced discrimination has been found to not be sig-
nificantly associated with antipsychotic medication
adherence for people living with schizophrenia [156].
Studies examining individuals with multiple stigma-
tized conditions suggest that the effects of health-related
stigma can be felt across all domains. Just as stigma
among individuals with mental health problems or injec-
tion drug use decreases their use of mental health and
substance disorder services, it also decreases HIV testing
and medication adherence. Unfortunately, the effects of
stigma across conditions are complex and, similar to
studies describing stigma in high-income countries [1],
our review found that studies of stigma and health out-
comes in LMICs are largely focused on one stigmatizing
condition (often only internalized stigma) and one health
outcome. Few studies described the complex interac-
tions between different types of stigma and the
co-occurring health conditions likely to be present.
As highlighted in Boxes 1, 2 and 3, the review results
showed that marginalized members of society are in-
creasingly vulnerable to health-related stigma. LGBTQ
individuals, racial and ethnic minorities, and refugees
suffer from increased stigma due to lack of social and
economic stability, fear of encountering stigma, and in-
creased self-stigmatization. Unequal access to treatment
and, among refugee communities, decreased access to
information, result in reduced healthcare-seeking behav-
iors. These associations can be amplified by perceived
stigma from the healthcare community, which further
delays care and reduces healthcare-seeking behavior.
The effects of trauma, particularly among LGBTQ indi-
viduals and refugees, are often under-recognized, which
also affects care. Unfortunately, as most studies recruit
participants from healthcare settings, these individuals
may have been overlooked within the available stigma
data, and particularly in that related to HIV, mental
health, and epilepsy. Similarly, difficulty in recruiting
these populations presents a research challenge and af-
fects data availability. Therefore, the effect of stigma on
the health and health outcomes of vulnerable popula-
tions may be underestimated. While the substance use
literature featured a wider range of populations, includ-
ing representation of sexual and gender minorities, as
well as geographies, the generalizability of this data is
limited by its focus on alcohol and injection drug use;
other substance types (e.g., inhalants, cocaine, prescrip-
tion drugs) that may have associations with stigma have
been largely neglected. Further, the effect of stigma on
child and adolescent populations is poorly understood as
only one study examining epilepsy-associated stigma fo-
cused on this vulnerable population [107]. Given that
risk factors, symptom presentation, and trajectories of
mental health and substance use problems may vary
across the life course, increased research on stigma
among children and adolescents is essential.
Comprehensive, multidisciplinary stigma-focused pre-
vention and treatment approaches are warranted in
LMICs. However, the design and implementation of
these interventions is limited by the data available. This
review highlights the paucity of longitudinal stigma stud-
ies on health-related stigma in LMICs, particularly
among community-based samples, which limits our un-
derstanding of the mechanisms by which stigma impacts
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health outcomes. Appropriately designed quantitative co-
hort studies are vital to addressing these issues. Further,
most of the studies included in this review were limited by
small sample size and, as a result, data regarding media-
tors of the association between stigma and health out-
comes is scant. Future research should include larger
sample sizes that would enable more complex path mod-
elling, including effect modification analysis. Available
data suggests that gender is a moderator of both TB-re-
lated and substance use stigma. Understanding the effects
of moderators and mediators on the relationship of stigma
with individual health outcomes will improve the effect-
iveness of stigma reduction interventions.
Limitations of the review
The purpose of the review was to inform both potential
future research studies and possible research questions
that could be addressed by systematic reviews. Formal
study inclusion and exclusion criteria were not used as
the review was not systematic; however, similar search
terms and databases were used across the five disease re-
views. Although the types of study designs described in
the literature were often noted, individual study quality
was not assessed, as is typical in scoping reviews. Finally,
we focused on five disease/disorders that significantly
drive the disease burden in LMICs. Future reviews
should focus on other stigmatized conditions affecting
individuals in this setting, including abortion, cancer,
leprosy, albinism, gender identity, sex work, sexual vio-
lence, and sexually transmitted infections.
Conclusion
A rapidly growing body of literature, mostly qualitative
and cross-sectional in design, suggests that stigma is as-
sociated with poor health outcomes, including less
help-seeking, among persons with HIV, TB, mental
health, neurologic disorders, and substance use. This re-
view highlights consistencies in the relationship of
stigma with health outcomes, but also common meth-
odological limitations. Future studies can address these
limitations by (1) recognizing that comorbidity is the
rule and not the exception and that the complex inter-
connected relationships between stigma and multiple
health outcomes must be accounted for in the study de-
sign phase; (2) measuring multiple types of stigma at
multiple health outcome levels; and (3) featuring longi-
tudinal designs, investigation into mediators and moder-
ators, and community-based study samples to improve
generalizability. Removing the siloes from health-related
stigma research in LMICs and addressing these limita-
tions will improve the epidemiological literature on
evidence-based stigma interventions, ultimately improv-
ing outcomes associated with high-burden diseases.
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